Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function

Clinical trial NCT00779922 · COMPLETED

Trial details

NCT number: NCT00779922
Sponsor: Poitiers University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Impaired Renal Function

Start date: 2008-11-01
Primary completion: 2012-09-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.